• Possibilities of non-hormonal correction of menstrual disorders in women of reproductive age

Possibilities of non-hormonal correction of menstrual disorders in women of reproductive age

HEALTH OF WOMAN. 2018.9(135):107–110; doi 10.15574/HW.2018.135.107

Semeniuk L. N.
Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine organs and tissues of the Ministry of Health of Ukraine, Kiev

The article presents new data on the prevention of reproductive disorders in women with functional hormonal imbalances. Disruption of the menstrual cycle is considered to be the combined result of hormonal dysfunction and the negative influence of the environment during chronic stress. The role of non-hormonal therapy in improving the quality of life and eliminating hormonal imbalance in women of reproductive age is shown.

Key words: female reproductive function, hormonal imbalance, proliferation.

REFERENCES

1. Semeniuk LM, Demianenko LV, Larina OV, Voronkova NM. (2017). Optymizatsiia prehravidarnoi pidhotovky zhinok z khronichnym tservitsytom ta dyshormonalnoiu ektopiieiu shyiky matky na tli ovuliatornoi dysfunktsii. Zbirnyk naukovykh prats Asotsiatsii akusheriv-ginekologiv Ukrainy. Vyp. 2(40):230–236.

2. Karabalin RS. (2007). Reproduktivnoe zdorove i sovershenstvovanie mediko-sotsialnoy pomoschi devushkam-uchaschimsya srednih i vyisshih uchebnyih zavedeniy (na primere g. Almatyi). Avtoref. diss. kand. med. nauk. Almatyi:26.

3. Soloveva AV, Raevskaya OA, Ipastova ID. (2018). Narusheniya menstrualnogo tsikla: pochemu ih nuzhno korrigirovat? Status Praesens. M. 1(44);04:52–59.

4. Podolskyi VV. (2003). Reproduktyvne zdorovia zhinok – vazhlyva problema suchasnosti. Zdorove zhenshchіnу 1(13):100–103.

5. Tatarchuk TF. (2006). Stress i reproduktivnaya funktsiya zhenschinyi. Mezhdunar. endokrinologiya 3:2–9.

6. Serov VN, Sidelnikova VM, Agadzhanova AA, Tetruashvili NK. (2003). Rannie poteri beremennosti – novoe ponimanie gormonalnyih narusheniy. Rus. med. zhurnal 11;16:907–908.

7. Frolova OG, Ryabinkina IN, Durasova NA. (2007). Reproduktivnoe zdorove naseleniya. Ros. med. zhurnal 5:3–5.

8. Practice Committee of the American Society for Reproductive Medicine. Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertil Steril 98 (2012):1112–7. https://doi.org/10.1016/j.fertnstert.2012.06.050; PMid:22819186

9. Practice Committee of the American Society for Reproductive Medicine. Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertil Steril 103:27–32. 2015. https://doi.org/10.1016/j.fertnstert.2014.12.128

10. Myers ER, Silva S, Barnhart K, Groben PA et al. (2004). NICHD National Cooperative Reproductive Medicine Network. «Interobserver and intraobserver variability in the histological dating of the endometrium in fertile and infertile women». Fertil Steril 82:1278–82. https://doi.org/10.1016/j.fertnstert.2004.04.058; PMid:15533342

11. Safronova DA. (2011). Reproduktivnoe zdorove zhenschin posle organosohranyayuschih operatsiy na yaichnikah. Avtoref. diss. kand. med. nauk: 21.

12. Volkov NI, Yusufbekova UYu. (2005). Funktsionalnoe sostoyanie yaichnikov u zhenschin reproduktivnogo vozrasta posle hirurgicheskogo udaleniya dobrokachestvennyih opuholey. Zhurnal Rossiyskogo obschestva akusherov-ginekologov 3:29–31.

13. Boyarskiy KYu, Gaydukov SN, Chinchaladze AC. (2009). Faktoryi, opredelyayuschie ovarialnyiy rezerv zhenschinyi. Zhurnal akusherstva i zhenskih bolezney LVIII;2:65–71.

14. Asratova IM. (1993). Korrektsiya narusheniy funktsii yaichnikov u patsientok s besplodiem posle vosstanovleniya prohodimosti matochnyih trub. Avtoref. diss. kand. med. nauk. M:26.

15. Bradlow et al. (1994). Long-responses of women to indol-3-carbinol. Cancer Epidemiol Biomarkers Prev. 7:591-595.

16. Smith TK, Mithen R, Johnson IT. (2003). Effects of Brassica vegetable juice on the induction of apoptosis and aberrant crypt foci in rat colonic mucosal crypts in vivo. Carcinogenesis 24(3):491-95. https://doi.org/10.1093/carcin/24.3.491; PMid:12663509

17. Arneson DW, Hurwitz A, McMahon LM et al. (1999). Presence of 3,3’-diindolylmethane in human plasma after oral administration of indole-3-carbinol. abstract 2833.

18. Proc Am Assoc Cancer Res 40, 429; Grose KR et al. (1992). Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188-193.

19. Atmaca N, Atmaca HT, Kanici A, Anteplioglu T. (2014). Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity in rats. Food Chem Toxicol: 245–78. https://doi.org/10.1016/j.fct.2014.05.011

20. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. (2000). Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141(10):3657–67. https://doi.org/10.1210/endo.141.10.7721; PMid:11014220

21. Li H, Fostermann U. (2009). Resveratrol: a multifunctional compound improving endothelial function. Cardiovasc Drugs Ther 23:425–9. https://doi.org/10.1007/s10557-009-6209-0; PMid:19937102 PMCid:PMC2797420

22. Semeniuk LM, Larina OV. (2018). Osoblyvosti kompleksnoi diahnostyky patolohii shyiky matky u zhinok iz syndromom polikistoznykh yaiechnykiv pry planuvanni hestatsiinoho debiutu. Zbirnyk naukovykh prats spivrobitnykiv KMAPO imeni P.L. Shupyka.Vyp. 29;1:157–163. K.

23. Ghanim H, Sia CL, Korzeniewski K et al. (2011). A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 96(5):1409–14. https://doi.org/10.1210/jc.2010-1812; PMid:21289251 PMCid:PMC3085195

24. Das S, Mitrovsky G, Vasanthi HR et al. (2014). Antiaging Properties of a Grape-Derived Antioxidant Are Regulated by Mitochondrial Balance of Fusion and Fission Leading to Mitophagy Triggered by a Signaling Network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014:345105. https://doi.org/10.1155/2014/345105; PMid:24669285 PMCid:PMC3942197

25. Zalesskiy VN, Velikaya NV, Omelchuk ST. (2014). Protivovospalitelnoe pitanie. Vinnitsa, Novaya kniga:735.